A Study of the Impact of Freezing on the Lyophilization of a Concentrated Formulation with a High Fill Depth

The objective of this study was to evaluate the impact of freezing on the lyophilization of a concentrated formulation with a high fill depth. A model system consisting of a 15-mL fill of 15% (w/w) sulfobutylether 7-beta-cyclodextrin (SBECD) solution in a 30-mL vial was selected for this study. Various freezing methods including single-step freezing, two-step freezing with a super-cooling holding, annealing, vacuum-induced freezing, changing ice habit using tert-butyl-alcohol (TBA), ice nucleation with silver iodide (AgI), as well as combinations of some of the methods, were used in the lyophilization of this model system. This work demonstrated that the freezing process had a significant impact on primary drying rate and product quality of a concentrated formulation with a high fill depth. Annealing, vacuum-induced freezing, and addition of either TBA or an ice nucleating agent (AgI) to the formulation accelerated the subsequent ice sublimation process. Two-step freezing or addition of TBA improved the product quality by eliminating vertical heterogeneity within the cake. The combination of two-step freezing in conjunction with an annealing step was shown to be a method of choice for freezing in the lyophilization of a product with a high fill depth. In addition to being an effective method of freezing, it is most applicable for scaling up. An alternative approach is to add a certain amount of TBA to the formulation, if the TBA-formulation interaction or regulatory concerns can be demonstrated as not being an issue. An evaluation of vial size performed in this study showed that although utilizing large-diameter vials to reduce the fill depth can greatly shorten the cycle time of a single batch, it will substantially decrease the product throughput in a large-scale freeze-dryer.

[1]  M. L. Roy,et al.  Freeze-drying of tert-butanol/water cosolvent systems: a case report on formation of a friable freeze-dried powder of tobramycin sulfate. , 2002, Journal of pharmaceutical sciences.

[2]  N. Bodor,et al.  Use of 2-Hydroxypropyl-β-cyclodextrin as a Solubilizing and Stabilizing Excipient for Protein Drugs , 1991, Pharmaceutical Research.

[3]  Thomas W. Patapoff,et al.  The importance of freezing on lyophilization cycle development , 2002 .

[4]  V. Stella,et al.  New injectable melphalan formulations utilizing (SBE)7m-β-CD or HP-β-CD , 1999 .

[5]  V. Vasudevan,et al.  Formulation development of protein dosage forms. , 2002, Pharmaceutical biotechnology.

[6]  H W Frijlink,et al.  Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent. , 2004, Journal of pharmaceutical sciences.

[7]  M. Pikal,et al.  Mass and heat transfer in vial freeze-drying of pharmaceuticals: role of the vial. , 1984, Journal of pharmaceutical sciences.

[8]  P. Deluca,et al.  The Effect of Tertiary Butyl Alcohol on the Resistance of the Dry Product Layer During Primary Drying , 1995, Pharmaceutical Research.

[9]  P. Cameron Good Pharmaceutical Freeze-Drying Practice , 1997 .

[10]  J. Oesterle,et al.  The influence of tertiary butyl alcohol and volatile salts on the sublimation of ice from frozen sucrose solutions: implications for freeze-drying. , 1998, Pharmaceutical development and technology.

[11]  Stanley E. Charm,et al.  Freeze Drying , 1964 .

[12]  W. Hook,et al.  Vapor pressure of ice between +10-2 and -1020 , 1970 .

[13]  James A. Searles Freezing and Annealing Phenomena in Lyophilization , 2004 .

[14]  Ingo Heschel,et al.  The influence of the freezing process on vapour transport during sublimation in vacuum-freeze-drying , 1991 .

[15]  David S. Baker,et al.  Practical aspects of lyophilization using non-aqueous co-solvent systems. , 2002, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[16]  V. Stella,et al.  New injectable melphalan formulations utilizing (SBE)(7m)-beta-CD or HP-beta-CD. , 1999, International journal of pharmaceutics.

[17]  J. Carpenter,et al.  Annealing to optimize the primary drying rate, reduce freezing-induced drying rate heterogeneity, and determine T(g)' in pharmaceutical lyophilization. , 2001, Journal of pharmaceutical sciences.

[18]  D O Thompson,et al.  Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. , 1997, Critical reviews in therapeutic drug carrier systems.

[19]  M. Pikal,et al.  Intravial distribution of moisture during the secondary drying stage of freeze drying. , 1997, PDA journal of pharmaceutical science and technology.

[20]  F. Veiga,et al.  Physicochemical investigation of the effects of water-soluble polymers on vinpocetine complexation with beta-cyclodextrin and its sulfobutyl ether derivative in solution and solid state. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  Geoffrey Lee,et al.  Freeze-drying using vacuum-induced surface freezing. , 2002, Journal of pharmaceutical sciences.

[22]  Thomas A. Jennings,et al.  Lyophilization: Introduction and Basic Principles , 1999 .

[23]  M. Pikal,et al.  Process control in freeze drying: determination of the end point of sublimation drying by an electronic moisture sensor. , 1989, Journal of parenteral science and technology : a publication of the Parenteral Drug Association.